ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » General Practice

Top General Practice Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
FRANK HRISOMALOS M.D.

General Practice

32,764

$1.73M

856
728 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

26%
patients receiving schedule three controlled substances

Avg: 20%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $59

JOHN KENNEDY MD

General Practice

20,945

$1.12M

436
318 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 20%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $59

ALEXANDER TON M.D.

General Practice

16,608

$1.06M

397
151 are 65+

21%
patients receiving schedule two controlled substances

Avg: 7%

42%
patients receiving schedule three controlled substances

Avg: 20%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $59

HENRY GINDT MD

General Practice

12,251

$2.03M

11775
9942 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

99%
prescriptions for brand name drugs

Avg: 25%

$165
Average prescription price

Avg: $59

ROBERT ABEL M.D.

General Practice

12,011

$555K

653
554 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 20%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $59

DANIEL WEGG MD

General Practice

11,978

$629K

517
412 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $59

HOMER SKAGGS MD

General Practice

10,933

$469K

232
102 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

59%
patients receiving schedule three controlled substances

Avg: 20%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $59

DESTRY LAMBERT MD

General Practice

10,676

$522K

419
380 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $59

BRETT EATON M.D.

General Practice

10,089

$466K

297
206 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

27%
patients receiving schedule three controlled substances

Avg: 20%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $59

JOHN MCCOLLUM MD

General Practice

9,323

$408K

315
259 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 20%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $59

DON STALLMAN MD

General Practice

8,786

$540K

280
139 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 20%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $59

PAUL GUISE MD

General Practice

8,196

$445K

246
120 are 65+

29%
patients receiving schedule two controlled substances

Avg: 7%

42%
patients receiving schedule three controlled substances

Avg: 20%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $59

JOHN COLLIP M.D.

General Practice

7,729

$576K

211
149 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

32%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$75
Average prescription price

Avg: $59

NICOLE BOERSMA MD

General Practice

7,060

$380K

392
197 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

37%
patients receiving schedule three controlled substances

Avg: 20%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $59

JAMES DRUMMOND MD

General Practice

6,452

$210K

106
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

59%
patients receiving schedule three controlled substances

Avg: 20%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$33
Average prescription price

Avg: $59

JERRY ADAMS MD

General Practice

6,182

$301K

191
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 20%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $59

WILLIAM GOUDY D.O.

General Practice

6,043

$304K

243
208 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 20%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $59

SEAN SHARMA M.D.

General Practice

6,031

$331K

246
211 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $59

JOEL MCGILL MD

General Practice

5,755

$290K

172
136 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $59

DONALD MADDACK DO

General Practice

5,461

$326K

306
277 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 20%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $59

JESSY WOODS M.D.

General Practice

5,219

$275K

262
164 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $59

MUTENA KORMAN M.D.

General Practice

5,057

$296K

153
101 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 20%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $59

PETER FARR M.D.

General Practice

4,803

$312K

307
181 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

26%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $59

PHILLIP SCOTT DO

General Practice

4,748

$230K

193
172 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

21%
patients receiving schedule three controlled substances

Avg: 20%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $59

PAOLO GIACOMINI MD

General Practice

4,567

$374K

402
61 are 65+

71%
patients receiving schedule two controlled substances

Avg: 7%

50%
patients receiving schedule three controlled substances

Avg: 20%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 25%

$82
Average prescription price

Avg: $59

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank